Literature DB >> 10945127

The effect of animal health products on the formation of injection site lesions in subprimals of experimentally injected beef calves.

J Van Donkersgoed1, P L Dubeski, M VanderKop, J L Aalhus, S Bygrove, W N Starr.   

Abstract

Two hundred and twenty beef calves were used in an experimental study to determine the occurrence of injection site lesions at slaughter (15 to 18 months of age) following subcutaneous and intramuscular injection of various products into the top hip (top butt), thigh (round), and neck or rib of calves at birth, branding, or weaning. Products tested were: 2 different preparations of selenium; a 2-way, a 7-way, and an 8-way clostridial bacterin; 2 combination 7-way clostridial and Haemophilus somnus bacterins; 2 H. somnus bacterins; 2 different 4-way modified-live viral respiratory vaccines; a 4-way killed viral and H. somnus vaccine; and penicillin, florfenicol, ceftiofur, trimethoprim-sulfa, and tilmicosin. The occurrence of lesions, number of steaks affected with lesions, the trim weight of lesions, the histological class of lesions, and the estimated economic losses are described. Generally, products administered subcutaneously in the neck produced minimal tissue damage and economic losses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10945127      PMCID: PMC1476228     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  5 in total

1.  The effect of vaccines and antimicrobials on the formation of injection site lesions in subprimals of experimentally injected beef calves.

Authors:  J Van Donkersgoed; P L Dubeski; J L Aalhus; M VanderKop; S Dixon; W N Starr
Journal:  Can Vet J       Date:  1999-04       Impact factor: 1.008

2.  A comparative study on irritation and residue aspects of five oxytetracycline formulations administered intramuscularly to calves, pigs and sheep.

Authors:  J F Nouws; A Smulders; M Rappalini
Journal:  Vet Q       Date:  1990-07       Impact factor: 3.320

3.  A survey of injection site lesions in fed cattle in Canada.

Authors:  J Van Donkersgoed; S Dixon; G Brand; M VanderKop
Journal:  Can Vet J       Date:  1997-12       Impact factor: 1.008

4.  Monitoring injection site lesions in Canadian yearling cattle and cull cows and bulls: Spring 1998.

Authors:  J Van Donkersgoed; S Dixon; M VanderKop
Journal:  Can Vet J       Date:  1999-08       Impact factor: 1.008

5.  Injection-site lesions in carcasses of cattle receiving injections at branding and at weaning.

Authors:  M H George; P E Heinrich; D R Dexter; J B Morgan; K G Odde; R D Glock; J D Tatum; G L Cowman; G C Smith
Journal:  J Anim Sci       Date:  1995-11       Impact factor: 3.159

  5 in total
  5 in total

1.  Vaccination against foot-and-mouth disease: the implications for Canada.

Authors:  Sarah Kahn; Dorothy W Geale; Paul R Kitching; Alice Bouffard; Denis G Allard; J Robert Duncan
Journal:  Can Vet J       Date:  2002-05       Impact factor: 1.008

2.  The ischiorectal fossa: an alternative route for the administration of prostaglandin in cattle.

Authors:  Marcos G Colazo; Marcelo F Martínez; John P Kastelic; Reuben J Mapletoft; Terry D Carruthers
Journal:  Can Vet J       Date:  2002-07       Impact factor: 1.008

3.  Acute toxicity study of tilmicosin-loaded hydrogenated castor oil-solid lipid nanoparticles.

Authors:  Shuyu Xie; Fenghua Wang; Yan Wang; Luyan Zhu; Zhao Dong; Xiaofang Wang; Xihe Li; Wenzhong Zhou
Journal:  Part Fibre Toxicol       Date:  2011-11-20       Impact factor: 9.400

4.  Superovulation with a single administration of FSH in aluminum hydroxide gel: a novel superovulation method for cattle.

Authors:  Koji Kimura
Journal:  J Reprod Dev       Date:  2016-07-11       Impact factor: 2.214

5.  Magnetic resonance imaging to detect local tissue reactions after vaccination in sheep in vivo.

Authors:  Maren Bernau; Prisca Valerie Kremer-Rücker; Lena Sophie Kreuzer; Sebastian Schwanitz; Klaus Cussler; Andreas Hoffmann; Armin Manfred Scholz
Journal:  Vet Rec Open       Date:  2017-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.